Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Clinical and Translational Science
|
April 16, 2025
A Patient-Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates
Alina Meyer, Bola Khalil, Margarita Iljin, et al.
Journal of Medicinal Chemistry
|
June 28, 2002
Identification of potent and novel alpha4beta1 antagonists using in silico screening
Juswinder Singh, Herman Van Vlijmen, Yusheng Liao, et al.
Journal of Chemical Theory and Computation
|
October 30, 2023
Alchemical Free Energy Calculations on Membrane-Associated Proteins
Michail Papadourakis, Hryhory Sinenka, Pierre Matricon, et al.
Journal of Computer-Aided Molecular Design
|
October 5, 2002
3D QSAR (COMFA) of a series of potent and highly selective VLA-4 antagonists
Juswinder Singh, Herman van Vlijmen, Wen-Chemg Lee, et al.
The Journal of Biological Chemistry
|
December 6, 2002
Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Pascal Schneider, Dian Olson, Aubry Tardivel, et al.
Journal of Computer-Aided Molecular Design
|
December 26, 2016
Collaborating to improve the use of free-energy and other quantitative methods in drug discovery
Bradley Sherborne, Veerabahu Shanmugasundaram, Alan C Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein
Dirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists
Hairuo Peng, Gnanasambandam Kumaravel, Gang Yao, et al.
Drug Discovery Today
|
January 20, 2024
The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programs
Herman van Vlijmen, Andrew D Pannifer, Phil Cochrane, et al.
Protein Engineering, Design & Selection : PEDS
|
May 10, 2006
Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody
Carl Reid, Mia Rushe, Matthew Jarpe, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Clinical and Translational Science
|
April 16, 2025
A Patient-Derived 3D Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates
Alina Meyer, Bola Khalil, Margarita Iljin, et al.
Journal of Medicinal Chemistry
|
June 28, 2002
Identification of potent and novel alpha4beta1 antagonists using in silico screening
Juswinder Singh, Herman Van Vlijmen, Yusheng Liao, et al.
Journal of Chemical Theory and Computation
|
October 30, 2023
Alchemical Free Energy Calculations on Membrane-Associated Proteins
Michail Papadourakis, Hryhory Sinenka, Pierre Matricon, et al.
Journal of Computer-Aided Molecular Design
|
October 5, 2002
3D QSAR (COMFA) of a series of potent and highly selective VLA-4 antagonists
Juswinder Singh, Herman van Vlijmen, Wen-Chemg Lee, et al.
The Journal of Biological Chemistry
|
December 6, 2002
Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Pascal Schneider, Dian Olson, Aubry Tardivel, et al.
Journal of Computer-Aided Molecular Design
|
December 26, 2016
Collaborating to improve the use of free-energy and other quantitative methods in drug discovery
Bradley Sherborne, Veerabahu Shanmugasundaram, Alan C Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein
Dirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists
Hairuo Peng, Gnanasambandam Kumaravel, Gang Yao, et al.
Drug Discovery Today
|
January 20, 2024
The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programs
Herman van Vlijmen, Andrew D Pannifer, Phil Cochrane, et al.
Protein Engineering, Design & Selection : PEDS
|
May 10, 2006
Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody
Carl Reid, Mia Rushe, Matthew Jarpe, et al.
Page
of 5